| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1723208A Magnesium salt of imidazole derivative |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723192A Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 01/18/2006 | CN1723021A Stable solid medicinal composition for oral administration. |
| 01/18/2006 | CN1721406A Process for the preparation of 2-aminomethylpyridines |
| 01/18/2006 | CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof |
| 01/18/2006 | CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237052C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/18/2006 | CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/18/2006 | CN1237050C Synthesis of 2,6-diaminemethylpyridine derivative fluoescence chemical sensor molecule and its application |
| 01/18/2006 | CN1236767C Vitronectin receptor antagonists |
| 01/17/2006 | US6987199 comprises activation of zinc metal in situ by adding catalytic amount of hydrochloric/sulfuric acid; for use as intermediate in synthesis of quinoline antibiotics (Ciprofloxacin, Levofloxacin, Gemifloxacin, and Trovafloxacin) |
| 01/17/2006 | US6987189 an aryl substituted (pyridin-2-ylmethylsulfanyl) alkyl amine; antibiotic |
| 01/17/2006 | US6987132 Enediyne compounds and methods related thereto |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/17/2006 | CA2218921C Preparation of a crystalline solid from glycine-n,n-diacetic acid derivatives with sufficiently low hygroscopicity |
| 01/12/2006 | WO2006004115A1 Remedy for hyperactive bladder |
| 01/12/2006 | WO2006003495A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | WO2006003494A2 Piperidine derivatives and their use as insecticides, acaricides, molluscicides or nematicides |
| 01/12/2006 | WO2006003378A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | WO2006003329A1 Collection of traceable compounds and uses thereof |
| 01/12/2006 | WO2006003277A1 Aromatic biaryl products, compositions containing same and use as medicines |
| 01/12/2006 | WO2006002802A1 Phenyl derivatives comprising an acetylene group |
| 01/12/2006 | WO2005094810A3 Novel pharmaceutical compositions |
| 01/12/2006 | WO2005077902A3 Methods for the synthesis of pyridoxamine |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009455 especially blood coagulation factor XIa and plasma kallikrein; e.g. 4-aminomethyl-[2-phenyl-1-(4-phenyl-pyridin-2-yl)-ethyl]-trans cyclohexanecarboxamide; anticoagulant, antiinflammatory agent; |
| 01/12/2006 | US20060009453 Protein kinase modulators and method of use |
| 01/12/2006 | US20060008673 Electroluminescent efficiency |
| 01/12/2006 | US20060008671 Electroluminescent efficiency |
| 01/12/2006 | US20060005320 N-alkylheteroaryl secondary para-phenylenediamine and composition comprising such a para-phenylenediamine |
| 01/12/2006 | DE102004031100A1 Anthranilamide Anthranilamides |
| 01/12/2006 | DE102004030099A1 Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines as serotonin and / or norepinephrine reuptake inhibitor and / or μ-opioid receptor modulators |
| 01/12/2006 | CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2570169A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | CA2569545A1 Collection of traceable compounds and uses thereof |
| 01/12/2006 | CA2568808A1 Chemical compounds |
| 01/12/2006 | CA2567020A1 Aromatic biaryl products, compositions containing same and use as medicines |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614676A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 01/11/2006 | EP1613613A2 Cxcr4 chemokine receptor binding compounds |
| 01/11/2006 | EP1613597A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/11/2006 | EP1613596A1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 01/11/2006 | EP1613595A2 Novel compounds and compositions as protein kinase inhibitors |
| 01/11/2006 | EP1613592A2 Hydroxamic acid compounds and methods of use thereof |
| 01/11/2006 | EP1613326A1 (3-{3-´(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino!-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 01/11/2006 | EP1613319A2 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/11/2006 | EP1613303A1 Substituted p-diaminobenzene derivatives |
| 01/11/2006 | EP1509573B1 Anthraquinone-azo dyes |
| 01/11/2006 | EP1322583B1 Method for the isomerisation of allyl alcohols |
| 01/11/2006 | EP1256342B1 Hypoglycemics comprising organic zinc (ii) complexes |
| 01/11/2006 | EP1056732B1 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases |
| 01/11/2006 | EP1028944B1 Fluorinated naphthalene derivatives and their use in liquid crystal mixtures |
| 01/11/2006 | CN1720244A Anthranilic acid amide derivatives and their pharmaceutical use |
| 01/11/2006 | CN1720243A Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 01/11/2006 | CN1720229A Method for photochemical halogenation |
| 01/11/2006 | CN1718573A Heterocyclic compound |
| 01/11/2006 | CN1718572A Process for preparing ring-fluorinated aromatics |
| 01/11/2006 | CN1235877C Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/11/2006 | CN1235856C Process for manufacture of phenylacetic acid derivatives |
| 01/10/2006 | US6984738 Reduction, catalytic hydrogenation |
| 01/10/2006 | US6984663 Cyclohexyl sulphones |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984642 for treating cardiovascular disorders, for example for the acute and chronic treatment of ischaemic disorders |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | CA2383332C Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/10/2006 | CA2262252C Method of treating heart failure |
| 01/05/2006 | WO2006001150A1 Polymer light-emitting material and organic light emitting element |
| 01/05/2006 | WO2006000358A1 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi |
| 01/05/2006 | WO2006000323A1 Novel hexafluoroisopropanol derivatives |
| 01/05/2006 | WO2002046150A3 Compounds which mimic the chemical and biological properties of discodermolide |
| 01/05/2006 | US20060004220 by phosgenation of an aminobenzoylsulfamic acid amide intermediate; prepared from a p-nitrobenzoyl chloride or benzoate and a sulfamic acid amide and reducing the nitrobenzoylsulfamic acid amide; isocyanates are crop protection agents |
| 01/05/2006 | US20060004206 Hydrogenating 3-chloro-2-cyano-5-trifluoromethylpyridine in acetic acid using Raney nickel at elevated temperature and pressure to give 2-aminomethyl-3-chloro-5-trifluoromethylpyridine; by-product inhibition; industrial scale |
| 01/05/2006 | US20060004205 Brominating a 2-alkoxy- or aryloxypyridine derivative, reacting the brominated pyridine with a magnesium Grignard agent, sulfonylating the organometallic pyridine, and hydrolyzing the product; industrial scale |
| 01/05/2006 | US20060004198 Method for producing substituted phenylsulfonyl urea |
| 01/05/2006 | US20060004197 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 01/05/2006 | US20060004091 Alpha-phenoxy- or phenylthio-alkanoic acid derivatives in which the phenyl ring is substituted with an acetylene group, e.g., 2-methyl-2-{2-methyl-4-[4-(4-trifluoromethyl-phenyl)-but-3-ynylsulfanyl]-phenoxy}-propionic acid; PPAR delta and/or PPAR alpha agonists used to treat diabetes |
| 01/05/2006 | US20060004068 Novel hexafluoroisopropanol derivatives |
| 01/05/2006 | US20060004066 Method for treating ADAMTS-5-associated disease |
| 01/05/2006 | US20060004063 Inhibitors of HCV NS5B polymerase |
| 01/05/2006 | US20060004062 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/05/2006 | US20060004061 reacting an anion of 4-amino-3,5-dichloropyridine containing potassium cation with an activated derivative of 3-cyclopropylmethoxy-4-difluoromethoxybenzoic acid in a solvent selected from dimethylformamide or N-methylpyrrolidone; potassium tert-butoxide is used to prepare the amine salt; intermediate |
| 01/05/2006 | US20060004056 Di-aryl-substituted-ethan pyridone pde4 inhibitors |
| 01/05/2006 | US20060004048 Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/05/2006 | US20060004041 Compounds for treatment of neurodegenerative diseases |
| 01/05/2006 | US20060002853 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 01/05/2006 | DE102004062258B3 New hydroxypyrimidone, hydroxypyridinone or dihydroxybenzene derivatives useful for preparing conjugates of biomolecules useful as magnetic resonance contrast agents |
| 01/05/2006 | DE102004028561A1 Verfahren zur Herstellung von 5-Arylnicotinaldehyden A process for the preparation of 5-Arylnicotinaldehyden |